by Jordana Choucair | Feb 28, 2022 | Life Sciences
Drugmaker Viatris Inc., formerly known as Mylan NV, will pay $264 million to settle a class-action lawsuit alleging it engaged in anticompetitive behavior to delay generic competition to its EpiPen allergy treatment. The litigation has been ongoing for years,...
by Jordana Choucair | Feb 28, 2022 | Public Health/Prevention
The CDC announced Friday it created new metrics for determining when people should use masks and take other COVID-19 precautions. The new benchmarks tie masking recommendations to a combination of a community’s level of cases, hospitalizations, and hospital...
by Jordana Choucair | Feb 28, 2022 | Public Health/Prevention
Only half of the 500 million COVID-19 tests that the White House made available to the public for free have been claimed. According to federal officials, 46 percent of tests have yet to be claimed and daily orders are down from 45 million the day the initiative...
by Jordana Choucair | Feb 25, 2022 | Transition to Value
The CMS announced it is replacing the Medicare direct contracting model with a similar accountable care organization model in 2023. The ACO Realizing Equity, Access, and Community Health (REACH) Model, a redesign of the Global and Professional Direct Contracting...
by Jordana Choucair | Feb 25, 2022 | Public Health/Prevention
The CDC is expected to relax federal mask guidance today, as it adopts new metrics to make its recommendations, including hospitalizations and local hospital capacity. The change means that based on current data, most Americans will no longer be advised to wear masks...
Recent Comments